JC82 (Medicine) - Monoarthropathy Flashcards

1
Q

List diseases that cause monoarticular symptoms

A

Septic arthritis: Bacterial, Mycobacterial, Lyme disease…etc

Crystal deposition diseases:

  • Gout
  • Pseudogout
  • Hydroxyapatite
  • Calcium oxalate

Trauma:

  • Fracture
  • ACL/ PCL tear
  • Hemarthrosis

Others:

  • OA
  • Juvenile idiopathic arthritis
  • Coagulopathy
  • Avascular necrosis of bone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List polyarticular diseases that sometimes present with monoarticular onset

A

RA

JIA

Viral arthritis

Spondyloarthritis (SpA)

  • Reactive arthritis
  • Psoriatic arthritis
  • IBD associated arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ddx the most likely cause of monoarticular pain over minutes, hours/days, weeks

A

Pain in Seconds/ minutes: Fracture, Hemarthrosis

Hours to days: Septic arthritis, Crystal deposition disease

Weeks: Inflammatory arthritis/ SpA, Indolent infection (TB), Osteoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ddx most likely causes of articular pain with recurrent acute attacks

A

Crystal arthritis: e.g. gout, pseudogout, hydroxyapatite, calcium oxalate

Inflammatory arthritis syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ddx most likely causes of articular pain with immunosuppression

A

Septic arthritis

Osteonecrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

First-line investigations for mono-articular pain

A

Synovial fluid aspiration and analysis:

  • Gross appearance
  • Microscopy
  • Microbiology

Blood:

  • CBC with diff.
  • ESR
  • Serum uric acid level
  • Prothrombin and Partial thromboplastin time
  • ANA, ACPA, autoimmune markers

Microbiology: Blood, urine, other sample culture

Others: Arthroscopy, X-ray of joint and contralateral side, Synovial biopsy, Other imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications of synovial fluid aspiration and analysis

A

Clinical suspicion of:

  • Infection
  • Crystal deposition disease
  • Hemarthrosis
  • Differentiate inflammatory and non-inflammatory arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List all tests done on synovial fluid analysis

A

Gross appearance

  • Color
  • Turbidity
  • Viscosity

Microscopy

  • Wet films
  • Cell stains and differential counts
  • Polarized light

Microbiology

  • Gram stain
  • Culture
  • Special stains: ZN stains, Fungal stains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Interpret the following profile of synovial fluid

High viscosity

Straw- yellow color

Transparent

WBC: 200-2000

PMN: <25%

A

Non-inflammatory arthritis/ Normal/ OA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Interpret the following profile of synovial fluid

Viscosity Low

Yellow color

Translucent

WBC: 2000-75000

PMN: >50%

A

Inflammatory arthritis e.g. RA, crystal deposition diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Interpret the following profile of synovial fluid

Variable viscosity, sometimes low, sometimes high

Variable color

Opaque

WBC >100,000

PMN: >75%

A

Septic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Interpret following synovial fluid analysis

Low viscosity

Red color

Slightly turbid

WBC: <200

PMN: <25%

A

Haemarthrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the function of polarized light microscopy on synovial fluid

A

Birefringent crystal in fluid alters vector of plane polarized light

Birefringence detected by color shift to blue (Positive) or yellow (Negative) when long axis of crystal is aligned with optical axis of the first order red compensator

Blue when parallel to optical axis of red compensator = Calcium pyrophosphate

Yellow (negative) when parallel to optical axis = Monosodium urate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Arthroscopy

Functions

Indication

A

Functions

  • Diagnostic: directly visualize articular surface, assess cartilage damage, take synovial biopsy
  • Therapeutic: Debridement of damaged cartilage, remove loose bodies, pain relief

Indications:

  • Pain relief
  • Inflammatory arthritis needing synovial biopsy
  • Remove fractured cartilage/ loose bodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Septic arthritis

  • Typical onset
  • Distribution
  • Routes of infection
A

Abrupt onset of monoarticular pain

Typically at large weight bearing joints e.g. hip, knee

Routes of infection:

  1. Hematogenous
  2. From adjacent Osteomyelitis
  3. Adjacent soft tissue infection
  4. Diagnostic/ therapeutic procedure contamination
  5. Penetrating injury by puncture or cut
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors of septic arthritis

A

Age under 5 or over 65

Medical:

  • Chronic arthritic diseases e.g. RA, OA, Crystal deposition diseases…etc
  • Chronic skin infections
  • Chronic systemic diseases: SLE< DM, Malignancy, Immunocompromised…etc

Iatrogenic:

  • Prosthetic joints
  • Intra-articular injections or arthrocentesis

Social:

  • Parenteral/ IV drug use
  • STDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Common causative bacteria for septic arthritis in:

Infant (<1 month)

Children <2 years old

A

Infants:

  • Streptococcal agalactiae
  • Gram negative bacilli e.g. E. coli
  • Staph. aureus

Children:

  • Hemophilus influenzae type B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Common causative bacteria of septic arthritis in:

Older children, adults, elderly, chronically ill

A

Staphylococcus auerus

Gram negative bacilli (chronically ill, elderly)

Neisseria gonorrhoeae (disseminated), Chlamydia trachomatis (reactive) (sexually active)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Common causative bacteria of septic arthritis in:

Prosthetic infection

Skin infection

IV drug users

Gas forming infection

A

Prosthetic: Staphylococcal aureus

Skin/ soft tissue infection: Streptococcal infection

IV DU: Gram negative bacilli, Pseudomonas aeruginosa, Staphylococcal aureus

Gas forming/ foul smelling; Anaerobes e.g. Clostridium difficile, Clostridium perfringens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Red flag features and approach/ first-line investigations to septic arthritis

A

Clinical Features:

  • Fever
  • Acute onset of hot, swollen and tender joint with restricted movement

Investigations:

  • Synovial fluid aspiration for microbiology: Negative gram smear or culture does not exclude sepsis
  • Blood culture, CBC, ESR, CRP
  • Electrolyte, RFT, LFT (detect end-organ damage, antibiotic use)
  • Imaging: X-ray and MRI

Promptly treat with antibiotics only AFTER joint aspiration

21
Q

Empirical antibiotics treatment for septic arthritis (typical organisms)

A

First-line: IV Flucloxacillin - 2g, 4 doses/ day

Penicillin-allergy:

  • IV Clindamycin 450-600mg QDS or
  • IV 2nd/ 3rd gen. cephalosporin
22
Q

Empirical antibiotics treatment for septic arthritis caused by:

  • Gram-negative sepsis
  • MRSA
  • Gonoccocus or meningococcus
A
  • Gram-negative sepsis: IV 2nd/ 3rd gen. cephalosporin
  • MRSA: IV Vancomycin + IV 2nd/3rd gen. cephalosporin
  • Gonoccocus or meningococcus: IV Ceftriaxone
23
Q

What conditions are associated with gram negative or MRSA spetic arthritis

A

Gram-negative: Elderly with chronic illness, Recurrent UTI, Recent abdominal surgery

MRSA: recent inpatient care, Leg ulcers, Nursing home residents, Long-term catheter insertion

24
Q

Which patient groups cannot be given empirical antibiotics for septic arthritis

A

IV Drug users

ITU/ ICU patients with known colonization of other organs

25
Q

Surgical treatment options for septic arthritis

A

Acute: Arthroscopy

Delayed or chronic: Open arthrotomy

Repeat surgical debridement until infection is controlled

26
Q

Intrinsic crystalline particles in crystal deposition diseases

A
  • Monosodium Urate monohydrate
  • Calcium Pyrophosphate Dihydrate CPPD
  • Calcium phosphate compounds e.g. hydroxyapatite, tricalcium phosphate, calcium oxalate
  • Lipids: Cholesterol, lipid crystals, Charcot-Leyden phospholipase crystals
  • Cystine
  • Xantine, Hypoxanthine
  • Protein precipitates e.g. cryoglobulins
27
Q

Extrinsic crystalline particles in crystal deposition disease

A

Synthetic corticosteroids

Plant thorns - Semi crystalloid cellulose e.g. blackthorn, rose thorn, dried palm fronds

Sea-urchin spines - Crystalline calcium carbonate

28
Q

Gout

  • Demographics
  • Joint distribution
  • Presentations
  • Diagnostic Ix
A

Demographics

  • M:F = 8:1
  • 30-60 years old

Joint distribution

  • First MTP in 20%

Presentations

  • Acute gouty arthritis with systemic upset
  • Intercritical gout
  • Chronic tophaceous gout

Diagnostic Ix: Urate crystals in synovial fluid aspiration

29
Q

Compare the presentation between acute, intercritical and chronic tophaceous gout

A

Acute: Monoarticular pain with systemic upset, Pruritus and desquamation of overlying skin

Intercritical: Asymptomatic between attacks, frequency and duration increases, becomes polyarticular

Chronic tophaceous gout: Late stage, continuous arthritis with superimposed acute attacks

30
Q

Areas affected by chronic tophaceous gout

A

Tophi in periarticular tissues, Helix of ear, Tendon sheaths

Late stage: Larynx. tongue, heart

31
Q

Gout

Associated diseases

Causes of hyperuricaemia

A

Associated diseases:

  • Obesity
  • Alcoholism
  • Type IV hyperlipoproteinemia
  • Impaired glucose tolerance
  • Ischemic heart disease
  • Hypertension

Pathogenesis:

  • Dietary excess of uric acid +/- Overproduction of urate Under-excretion of urate
32
Q

Outline the production and excretion cycle of uric acid

A
33
Q
A
34
Q

Causes of overproduction of uric acid

A

Primary hyperurecaemia

  • Idiopathic
  • HGPRT deficiency - cannot convert hypoxanthine to xanthine
  • PRPP synthase superactivity - cannot convert 5-phosphoribosyl 1-pyrophosphate to PRPP glutamine

Secondary hyperurecaemia

  • Excessive purine intake
  • Myeloproliferative/ lymphoproliferative diseases/ Hemolytic diseases - increase cell breakdown
  • Psoriasis
  • Glycogen storage diseases type 1,3,5,7
35
Q

Causes of under-secretion of uric acid

A

Primary: idiopathic

Secondary:

  • Poor renal function
  • Metabolic acidosis
  • Dehydration, Diuretics
  • Hypertension
  • Hyperparathyroidism
  • Drugs: Cyclosporine, Pyrazinamide, Ethambutol, Salicylate
  • Lead nephropathy
36
Q

Gout

Acute treatment options

A

Pain relief and acute management

  • NSAID (avoid aspirin or salicylates)
  • COX-2 selective inhibitors - Etoricoxib
  • Colchicine
  • Steroids
  • Anti-IL1 injection: Anakinra, Canakinumab
37
Q

Describe the molecular pathway for urate crystals to trigger inflammatory response and articular damage

A

Signal 1 = innate immune response against pathogen

TLR at plasma membrane activated > NF-kB pathway > inflammasome response

Signal 2 = monosodium urate crystal > engulfed by macrophage > inflammasome > capase 1 to cleave pro-IL1 to IL1 > Release IL1 to extracellular space > draw more WBC to site of infection (chemotactic factor) for inflammatory response + fever

38
Q

Gout

Long-term management objective and drug options

A

Prevent recurrent attacks, formation of tophi and articular damage

Prophylaxis: Colchicine or NSAID for 3 months to prevent breakthrough attacks

Xanthine oxidase inhibitors: (C/I Azathioprine, synergistic toxicity)

  • Allopurinol
  • Febuxostat (for impaired kidney function, C/I liver dysfunction)

Uricosuric agents:

  • Probenecid, benzbromarone
  • Sulphinpyrazone

Urate lowering agents:

  • Pegloticase (recombinant uricase)
  • Lesinurad: URAT1 inhibitor
39
Q

C/I uricosuric agents

A

Primary overproduction of urate

Gross hyperuricosuria

Urolithiasis

Renal insufficiency

40
Q

Toxic S/E of drugs for long-term Gout control

A

TEN and vasculitis - Allopurinol

Nephrotic syndrome - Probenecid

Hepatitis and BM suppression - Hypouricaemic drugs

41
Q

Indications for hypourcaemic agents (allopurinol, rasburicase…etc)

A

Indications for hypouricaemic drugs:

  • Recurrent acute attacks
  • Tophi, chronic joint damage

(Contraindications for uricosuric agents)
* Renal disease
* Young patient with hyperuricaemia
* Family history of renal and heart disease
* Primary purine overproduction and under-secretion

42
Q

Pseudogout/ Chondrocalcinosis

Demographics

Joints affected

Crystal

A

Demographics: Elderly, M:F = 1.4:1

Joint: Knee most common

Calcium Pyrophosphate - Rhomboid crystals

43
Q

Pseudogout

Causes

A

Hereditary

Idiopathic (elderly)

Metabolic diseases:

  • Hyperparathyroidism
  • Haemachromatosis
  • Hypothyroidism
  • Gout
  • Hypomagnesemia
  • Hypophosphatasia
44
Q

Pseudogout

Treatment options

A

Majority asymptomatic - no Tx

Supportive measures: ice pack, immobilization, joint rest

Joint aspiration + intra-articular glucocorticoid injection

Systemic anti-inflammatory drug if >2 joints involved:

  • Choice: NSAIDs (caution on C/I in elderly), colchicine (first 24h), oral steroids
45
Q

Haemarthrosis

Common causes

Symptoms

Diagnostic Ix

Tx

A

Causes:

  1. Trauma
  2. Hemophilia
  3. Acquired hemophilia
  4. Anti-platelet or anti-coagulants

S/S: Pain, swelling, stiffness (non-specific)

Diagnostic Ix: Arthrocentesis

Tx: Underlying cause

46
Q

Xanthine oxidase inhibitor

Examples

MoA

S/E

D/D interactions

A

allopurinol and febuxostat

Initiation: start only after resolution of flare

MoA: block xanthine oxidase = increase conversion of hypoxanthine into xanthine into uric acid for urine excretion

S/E: rash, leukopenia/thrombocytopenia, diarrhoea (3-5%), xanthine stones, severe cutaneous reactions, DRESS syndrome

47
Q

Uricosuric agents

Examples

MoA

Indications

S.E

A

probenecid, benzbromarone

MoA: inhibit PCT urate-anion exchangers → ↓urate reabsorption → ↑↑urate excretion

Indication: impaired urate excretion, used in combination with XOI for refractory to monotherapy

S/E: rash, precipitation of gout flare, GI intolerance, urate stone formation
Probenecid S/E = Precipitation of gout, Rash, Obstruction (urate stone), Bowels (GI upset)

48
Q

Recombinant uricase

Examples

MoA

S/E

A

eg. pegloticase (for gout), rasburicase (for TLS, not for gout)

→ MoA: enzyme that catalyzes conversion of urate into more soluble allantoin for excretion

S/E: may develop Ab vs pegloticase → ↓therapeutic response → limiting factor for long-term treatment

49
Q

Radiological features of pseudogout

A

→ Chondrocalcinosis: irregular faint punctate/linear
radiodensities in articular cartilage

→ Degenerative changes: subchondral cysts, osteophytes, ↓joint space

→ Other features in specific joints:

  • MCPJ: squared off bone ends and hook-like MPCJ
  • Wrist: isolated/unusually extensive radiocarpal joint narrowing
  • PFJ: severe space degeneration